TYRO3
MOLECULAR TARGETTYRO3 protein tyrosine kinase
TYRO3 (TYRO3 protein tyrosine kinase) is targeted by 23 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TYRO3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | erlotinib | 5.55 | 256 |
| 2 | foretinib | 4.34 | 76 |
| 3 | vandetanib | 4.30 | 73 |
| 4 | bosutinib | 4.08 | 58 |
| 5 | midostaurin | 3.85 | 46 |
| 6 | nintedanib | 3.61 | 36 |
| 7 | canertinib | 3.53 | 33 |
| 8 | pelitinib | 3.50 | 32 |
| 9 | tae 684 | 3.43 | 30 |
| 10 | bms 777607 | 3.37 | 28 |
| 11 | mln 8054 | 3.33 | 27 |
| 12 | dovitinib | 3.09 | 21 |
| 13 | lestaurtinib | 3.04 | 20 |
| 14 | r 406 | 2.83 | 16 |
| 15 | cediranib | 2.83 | 16 |
| 16 | pha 665752 | 2.71 | 14 |
| 17 | bemcentinib | 2.64 | 13 |
| 18 | su 014813 | 2.20 | 8 |
| 19 | rebastinib | 2.20 | 8 |
| 20 | itacitinib | 1.95 | 6 |
| 21 | Crizotinib | 0.69 | 1 |
| 22 | sp600125 | 0.69 | 1 |
| 23 | bdb chembl2018022 | 0.69 | 1 |
About TYRO3 as a Drug Target
TYRO3 (TYRO3 protein tyrosine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 23 compounds with documented TYRO3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TYRO3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.